The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 15, 2016
Filed:
Apr. 22, 2014
Applicant:
Foamix Ltd., Rehovot, IL;
Inventors:
Assignee:
Foamix Pharmaceuticals Ltd., Rehovot, IL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/12 (2006.01); A61K 9/00 (2006.01); A61K 8/02 (2006.01); A61K 31/19 (2006.01); A61K 31/17 (2006.01); A61K 31/196 (2006.01); A61K 8/04 (2006.01); A61K 8/06 (2006.01); A61K 8/31 (2006.01); A61K 9/107 (2006.01); A61Q 17/02 (2006.01); A61Q 19/00 (2006.01); A61Q 19/10 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61K 8/42 (2006.01); A61K 31/167 (2006.01); A61K 31/497 (2006.01); A01N 25/16 (2006.01); A61K 8/365 (2006.01); A61Q 19/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/196 (2013.01); A01N 25/16 (2013.01); A61K 8/046 (2013.01); A61K 8/06 (2013.01); A61K 8/062 (2013.01); A61K 8/31 (2013.01); A61K 8/365 (2013.01); A61K 8/42 (2013.01); A61K 9/0014 (2013.01); A61K 9/107 (2013.01); A61K 9/12 (2013.01); A61K 9/122 (2013.01); A61K 31/167 (2013.01); A61K 31/17 (2013.01); A61K 31/19 (2013.01); A61K 31/497 (2013.01); A61K 45/00 (2013.01); A61K 45/06 (2013.01); A61Q 17/02 (2013.01); A61Q 19/00 (2013.01); A61Q 19/08 (2013.01); A61Q 19/10 (2013.01); A61K 2800/75 (2013.01); Y10S 514/945 (2013.01);
Abstract
The invention relates to an alcohol-free cosmetic or pharmaceutical foam composition comprising water, a hydrophobic solvent, a surface-active agent, a gelling agent, an active component selected from the group of urea, hydroxy acid and a therapeutic enhancer and a propellant. The foam further comprises active agents and excipients with therapeutic properties having enhanced skin penetration.